[A Patient with Recurrent Ulcerative Colitis-Associated Rectal Cancer Attaining a Complete Response with FOLFIRI plus Bevacizumab].

Abstract

A 60-year-old man underwent laparoscopic total proctocolectomy with ileostomy for advanced ulcerative colitis-associated rectal cancer. The final diagnosis was advanced cancer pT3, pN2 and M0 (pStage Ⅲb). Adjuvant therapy with XELOX was performed. However, abdominal CT revealed a liver metastasis and lymph node metastases in the pelvis 6 months after… (More)

Topics

Cite this paper

@article{Iseki2015APW, title={[A Patient with Recurrent Ulcerative Colitis-Associated Rectal Cancer Attaining a Complete Response with FOLFIRI plus Bevacizumab].}, author={Yasuhito Iseki and Kiyoshi Maeda and Masatsune Shibutani and Hisashi Nagahara and Tetsuro Ikeya and Tatsuro Tamura and Go Ohira and Katsunobu Sakurai and Sadaaki Yamazoe and Kenjiro Kimura and Takahiro Toyokawa and Naoshi Kubo and Hiroaki Tanaka and Kazuya Muguruma and Kosei Hirakawa}, journal={Gan to kagaku ryoho. Cancer & chemotherapy}, year={2015}, volume={42 12}, pages={2205-7} }